Literature DB >> 32093736

Circadian expression of Fabp7 mRNA is disrupted in Bmal1 KO mice.

Jason R Gerstner1,2,3, Georgios K Paschos4.   

Abstract

The astrocyte brain-type fatty acid binding protein (Fabp7) gene expression cycles globally throughout mammalian brain, and is known to regulate sleep in multiple species, including humans. The mechanisms that control circadian Fabp7 gene expression are not completely understood and may include core circadian clock components. Here we examined the circadian expression of Fabp7 mRNA in the hypothalamus of core clock gene Bmal1 knock-out (KO) mice. We observed that the circadian rhythm of Fabp7 mRNA expression is blunted, while overall Fabp7 mRNA levels are significantly higher in Bmal1 KO compared to control (C57BL/6 J) mice. We did not observe any significant changes in levels of hypothalamic mRNA expression of Fabp3 or Fabp5, two other fatty acid binding proteins expressed in mammalian brain, between Bmal1 KO and control mice. These results suggest that Fabp7 gene expression is regulated by circadian processes and may represent a molecular link controlling the circadian timing of sleep with sleep behavior.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32093736      PMCID: PMC7041087          DOI: 10.1186/s13041-020-00568-7

Source DB:  PubMed          Journal:  Mol Brain        ISSN: 1756-6606            Impact factor:   4.041


Main text

Sleep behavior is exhibited by virtually every species studied, while the precise function of sleep remains unknown. Understanding the underlying cellular and molecular mechanisms that relay sleep behavior may resolve important clues as to sleep function. Sleep is thought to be governed by two processes, a circadian system, which controls the daily timing of sleep, and a homeostatic system, which regulates sleepiness based on previous time spent awake [1, 2]. Circadian rhythms are regulated by a well-defined and phylogenetically conserved transcriptional/translational autoregulatory negative feedback loop [3], which includes the core clock gene Bmal1 [4]. Bmal1 is a basic helix-loop-helix transcription factor known to heterodimerize with core circadian factors CLOCK or NPAS2 and bind to E-box elements in the promoter of downstream target genes to influence circadian their transcriptional output and behavior [5, 6]. Deletion of Bmal1 is the only single gene deletion that disrupts circadian clock function, whereas single gene deletion of other clock components only leads to attenuated circadian rhythms [7]. However, exactly how this circadian clock shapes molecular events that in turn regulate sleep behavior are not well understood. Fatty-acid binding proteins (Fabp) comprise a family of small (~ 15 kDa) hydrophobic ligand binding carriers with high affinity for long-chain fatty-acids for intracellular transport, and are associated with metabolic, inflammatory, and energy homeostasis pathways [8, 9]. These include three that are expressed in the adult mammalian central nervous system (CNS), and are Fabp3 (H-Fabp), Fabp5 (E-Fabp), and Fabp7 (B-Fabp). Fabp3 is predominantly expressed in neurons, Fabp5 is expressed in multiple cell types, including both neurons and glia, and Fabp7 is enriched in astrocytes and neural progenitors. Fabp7 mRNA was identified as a unique transcript elevated in multiple hypothalamic brain regions of mice during the sleep phase [10], and Fabp7 is also known to regulate sleep in flies, mice, and humans [11]. Here we were interested in determining whether circadian Fabp7 mRNA expression is disrupted in mice that lack the core circadian clock gene Bmal1. To test whether circadian Fabp7 mRNA expression is regulated by the core molecular clock, we compared Fabp7 transcript levels in hypothalamus of Bmal1 KO to wild-type (WT) littermate control C57BL/6 J mice using qPCR analysis. We observed that baseline levels of Fabp7 mRNA expression in the Bmal1 KO mouse were higher compared to WT littermate controls, irrespective of circadian time (Fig. 1a, Fig. S1), while the circadian expression of Fabp7 mRNA was completely ablated in Bmal1 KO mice compared to controls (Fig. 1b). In order to test whether other CNS expressing Fabps have altered mRNA expression as a result of Bmal1 deficiency, we profiled Fabp3 and Fabp5 and found that neither the baseline expression or circadian pattern of these transcripts were affected by Bmal1 (Fig. 1a, b), suggesting that among Fabps expressed in the CNS, both the baseline and circadian profile of transcription affected by the core clock is Fabp7 specific.
Fig. 1

Increased baseline Fabp7 mRNA expression, and disruption of its circadian rhythm, in Bmal1 KO. (a) Average expression of hypothalamic Fabp7 mRNA is ~7fold greater in BMAL KO compared to WT mice, while Fabp3 mRNA and Fabp5 mRNA are stable (n = 18 per group). ***p < 0.001 Fabp7 mRNA KO/WT vs. Fabp3 mRNA or Fabp5 mRNA KO/WT (t-test). (b) Normalized mRNA expression values (to mean of circadian values within each group) of various Fabps depicts the circadian oscillation of Fabp7 mRNA in C57BL/6 WT which is absent in BMAL KO mice (n = 3 per group per timepoint). Fabp7 mRNA shows a significant circadian dependent change in expression based on genotype. Two-way ANOVA (p < 0.001). ***p < 0.001, **p < 0.01, *p < 0.05 vs ZT0 (post-hoc Bonferroni), while there is no significant difference for circadian variation of Fabp7 mRNA in BMAL KO mice

Increased baseline Fabp7 mRNA expression, and disruption of its circadian rhythm, in Bmal1 KO. (a) Average expression of hypothalamic Fabp7 mRNA is ~7fold greater in BMAL KO compared to WT mice, while Fabp3 mRNA and Fabp5 mRNA are stable (n = 18 per group). ***p < 0.001 Fabp7 mRNA KO/WT vs. Fabp3 mRNA or Fabp5 mRNA KO/WT (t-test). (b) Normalized mRNA expression values (to mean of circadian values within each group) of various Fabps depicts the circadian oscillation of Fabp7 mRNA in C57BL/6 WT which is absent in BMAL KO mice (n = 3 per group per timepoint). Fabp7 mRNA shows a significant circadian dependent change in expression based on genotype. Two-way ANOVA (p < 0.001). ***p < 0.001, **p < 0.01, *p < 0.05 vs ZT0 (post-hoc Bonferroni), while there is no significant difference for circadian variation of Fabp7 mRNA in BMAL KO mice Circadian Fabp7 mRNA expression has been shown to be regulated by the nuclear hormone receptor Rev-erbα (NR1D1), a transcriptional repressor, via Rev-erbα response elements (ROREs) in the Fabp7 gene promoter [12]. Since Bmal1 deficiency greatly suppresses Rev-erbα expression, it is likely that the circadian regulation of Fabp7 mRNA by Bmal1 is through Rev-erbα. Studies determining whether Bmal1 regulates Fabp7 mRNA indirectly via Rev-erbα or whether the Fabp7 gene promoter also has functional E-box binding sites will be crucial for identifying the clock-regulated expression of this gene. Fabp7 mRNA expression was also shown to be upregulated in mice with deletion of Bmal1 in neurons and astrocytes [13]. Future studies using cell-specific knock-down of Bmal1 to determine whether disruption of core clock genes in astrocytes regulates circadian Fabp7 mRNA expression will be important for our understanding of how clock-controlled genes in non-neural cells regulate pathways affecting behavior. For example, recent studies show that astrocytes are able to regulate daily rhythms in the master circadian pacemaker of the hypothalamus, the suprachiasmatic nucleus (SCN), and circadian behavior [14, 15]. Further, post-transcriptional processing mechanisms known to operate on Fabp7 mRNA targeting to perisynaptic processes [16] will be important to characterize following circadian clock disruption in astrocytes. Determining whether circadian Fabp7 expression is necessary for daily rhythms in SCN and extra-SCN physiology [17] and related behavior are additional avenues for future study. Additional file 1. Additional file 2.
  17 in total

1.  The two-process model of sleep regulation: a reappraisal.

Authors:  Alexander A Borbély; Serge Daan; Anna Wirz-Justice; Tom Deboer
Journal:  J Sleep Res       Date:  2016-01-14       Impact factor: 3.981

2.  Time of day regulates subcellular trafficking, tripartite synaptic localization, and polyadenylation of the astrocytic Fabp7 mRNA.

Authors:  Jason R Gerstner; William M Vanderheyden; Timothy LaVaute; Cara J Westmark; Labib Rouhana; Allan I Pack; Marv Wickens; Charles F Landry
Journal:  J Neurosci       Date:  2012-01-25       Impact factor: 6.167

3.  Astrocytes Regulate Daily Rhythms in the Suprachiasmatic Nucleus and Behavior.

Authors:  Chak Foon Tso; Tatiana Simon; Alison C Greenlaw; Tanvi Puri; Michihiro Mieda; Erik D Herzog
Journal:  Curr Biol       Date:  2017-03-23       Impact factor: 10.834

4.  Cell-Autonomous Regulation of Astrocyte Activation by the Circadian Clock Protein BMAL1.

Authors:  Brian V Lananna; Collin J Nadarajah; Mariko Izumo; Michelle R Cedeño; David D Xiong; Julie Dimitry; Chak Foon Tso; Celia A McKee; Percy Griffin; Patrick W Sheehan; Jeffery A Haspel; Ben A Barres; Shane A Liddelow; Joseph S Takahashi; Ilia N Karatsoreos; Erik S Musiek
Journal:  Cell Rep       Date:  2018-10-02       Impact factor: 9.423

5.  Profiles of novel diurnally regulated genes in mouse hypothalamus: expression analysis of the cysteine and histidine-rich domain-containing, zinc-binding protein 1, the fatty acid-binding protein 7 and the GTPase, ras-like family member 11b.

Authors:  J R Gerstner; W M Vander Heyden; T M Lavaute; C F Landry
Journal:  Neuroscience       Date:  2006-03-06       Impact factor: 3.590

Review 6.  Fatty acid-binding proteins: role in metabolic diseases and potential as drug targets.

Authors:  Masato Furuhashi; Gökhan S Hotamisligil
Journal:  Nat Rev Drug Discov       Date:  2008-06       Impact factor: 84.694

7.  Intercellular coupling confers robustness against mutations in the SCN circadian clock network.

Authors:  Andrew C Liu; David K Welsh; Caroline H Ko; Hien G Tran; Eric E Zhang; Aaron A Priest; Ethan D Buhr; Oded Singer; Kirsten Meeker; Inder M Verma; Francis J Doyle; Joseph S Takahashi; Steve A Kay
Journal:  Cell       Date:  2007-05-04       Impact factor: 41.582

Review 8.  Molecular components of the Mammalian circadian clock.

Authors:  Ethan D Buhr; Joseph S Takahashi
Journal:  Handb Exp Pharmacol       Date:  2013

9.  The nuclear receptor REV-ERBα regulates Fabp7 and modulates adult hippocampal neurogenesis.

Authors:  Anna Schnell; Sylvie Chappuis; Isabelle Schmutz; Emanuele Brai; Jürgen A Ripperger; Olivier Schaad; Hans Welzl; Patrick Descombes; Lavinia Alberi; Urs Albrecht
Journal:  PLoS One       Date:  2014-06-16       Impact factor: 3.240

10.  Normal sleep requires the astrocyte brain-type fatty acid binding protein FABP7.

Authors:  Jason R Gerstner; Isaac J Perron; Samantha M Riedy; Takeo Yoshikawa; Hiroshi Kadotani; Yuji Owada; Hans P A Van Dongen; Raymond J Galante; Kaitlin Dickinson; Jerry C P Yin; Allan I Pack; Marcos G Frank
Journal:  Sci Adv       Date:  2017-04-05       Impact factor: 14.136

View more
  4 in total

1.  A Dichotomous Role for FABP7 in Sleep and Alzheimer's Disease Pathogenesis: A Hypothesis.

Authors:  Hope Needham; Grace Torpey; Carlos C Flores; Christopher J Davis; William M Vanderheyden; Jason R Gerstner
Journal:  Front Neurosci       Date:  2022-06-30       Impact factor: 5.152

2.  Circadian-Dependent and Sex-Dependent Increases in Intravenous Cocaine Self-Administration in Npas2 Mutant Mice.

Authors:  Lauren M DePoy; Darius D Becker-Krail; Wei Zong; Kaitlyn Petersen; Neha M Shah; Jessica H Brandon; Alyssa M Miguelino; George C Tseng; Ryan W Logan; Colleen A McClung
Journal:  J Neurosci       Date:  2020-12-02       Impact factor: 6.167

3.  The transcriptional repressor Rev-erbα regulates circadian expression of the astrocyte Fabp7 mRNA.

Authors:  William M Vanderheyden; Bin Fang; Carlos C Flores; Jennifer Jager; Jason R Gerstner
Journal:  Curr Res Neurobiol       Date:  2021-03-23

Review 4.  The Molecular Genetic Interaction Between Circadian Rhythms and Susceptibility to Seizures and Epilepsy.

Authors:  Christopher J Re; Alexander I Batterman; Jason R Gerstner; Russell J Buono; Thomas N Ferraro
Journal:  Front Neurol       Date:  2020-06-23       Impact factor: 4.003

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.